Sex Chromosome Evolution: Culture shock
Many different human cell lines, including both normal and cancer cells, appear to converge to a state that contains an unusual number of chromosomes when they are grown in culture.
- Fred Hutchinson Cancer Research Center, United States
In many organisms, sex is determined by chromosomes. In humans and other animals, for example, females possess two X chromosomes, whereas males have one X and one Y chromosome. This means that females can have two copies of some of the genes that are found on the X chromosome, whereas males have only one copy of these genes. Humans also contain 22 pairs of other chromosomes, known as autosomes, and it is thought that the X and Y chromosomes evolved from these (Bachtrog, 2013; Charlesworth, 1991).
Various organisms have evolved different strategies to cope with the potential dosage imbalance between X and autosomal genes. For example, many female mammals – including humans – deactivate one of their X chromosomes, while some worms down-regulate both X chromosomes (Bachtrog et al., 2014). Some male insects and lizards, on the other hand, are known to up-regulate their X chromosome (Marin et al., 2017). Each of these strategies increases the chances of survival at the level of individuals and species, but is the same true at the level of cells? Now, in eLife, Chung-I Wu, Xuemie Lu and co-workers – including Jin Xu, Xinxin Peng and Yuxin Chen as joint first authors – report that this might not be the case (Xu et al., 2017).
Xu et al. used a technique called SNP genotyping to count the number of autosomes and sex chromosomes in 620 human cell lines derived from normal or cancerous cells that had been grown in the laboratory for varying amounts of time. Normal cells cannot be grown in culture for long periods of time before undergoing senescence, so they must undergo some form of transformation (such as infection with the Epstein-Barr virus) to immortalize them. SNP genotyping can also measure genetic variation by detecting if a cell is homozygous (that is, if the alleles at a given locus are the same) or heterozygous (that is, if the alleles are different). The results showed that, over time, both male and female cells changed into a ‘de-sexualized state’: male cells lost their Y chromosome, while females lost their inactive X chromosome, leaving both with just one X chromosome. However, following the establishment of this de-sexualized state, many of the male and female cells acquired a duplicate of their X chromosome, which resulted in a state with two active X chromosomes (Figure 1).
Figure 1
The evolution of human cells in culture.
In humans, female cells have 22 pairs of chromosomes, an active X chromosome (Xa) and an inactive X chromosome (Xi), whereas male cells have 22 pairs of chromosomes, an X chromosome and a Y chromosome. Cells derived from human cancers often are aneuploid and contain altered numbers of chromosomes, which have frequently undergone rearrangements from the canonical state. However, when grown in cell culture, both female and male cells (and also both normal and cancer-derived cells) can evolve into a ‘de-sexualized state’ that contains a single X chromosome. In these de-sexualized cells, the X chromosome frequently undergoes a duplication, which is followed by the duplication of one full set of autosomal chromosomes to produce an X:A=2:3 state that contains 68 chromosomes on average (as opposed to 46); this state appears to have been repeatedly selected for in cell culture conditions.
Xu et al. – who are based at institutions in Guangzhou, Beijing, Houston, Stanford and Chicago – then turned their attention to the autosomes and discovered that the cell lines tried to maintain an equal number of all autosomes: in other words, cells tried to have two copies of every autosomal chromosome (an A=2 state) or three copies (A=3). Cells generally evolved from a state with two copies of each autosomal chromosome and two sex chromosomes, to the de-sexualized state which has just one X chromosome and a X:A ratio of 1:2, into a state with a duplicated X chromosome (that is, X:A=2:2) and then, on other occasions, a state in which there are two X chromosomes and three copies of every autosomal chromosome (X:A=2:3; see Figure 1).
As expected the most common X:A ratio was 1:2 but, somewhat surprisingly, X:A=2:3 was the second most common ratio. Xu et al. then modeled their system and found, again to their surprise, that the different ratios were predicted to have different fitness levels. Moreover, the cells were evolving towards a ratio of 2:3, irrespective of how long they had spent in the culture and whether they originally were normal or cancer cells. This probably happens to balance the expression of the genes on the duplicated X chromosomes and the genes on the autosomes.
Xu et al. suggest that the evolution towards a ratio of 2:3 may reflect these cells absolving themselves of some of the functions that cells need to perform in multicellular organisms (Merlo et al., 2006; Chen et al., 2015); for example, if they had remained part of a multicellular organism they would not have been able to jettison superfluous sex chromosomes. The work is particularly interesting because such a unicellular state might lead to the high rates of cell division that are characteristic of cancer.
Evidence for such convergent evolution in cancer cells is growing (Chen and He, 2016; Fortunato et al., 2017). So, just as cancer cells evolve to disobey the constraints of multicellular life (Merlo et al., 2006), the cells in a culture may undergo a form of reverse evolution to a unicellular state (Chen et al., 2015). However, the fact that both normal cells and cancerous cells follow similar rules leaves open the possibility that the preference for the 2:3 ratio is linked to culture conditions, or the transformation method used to immortalize the normal cells, rather than any evolution towards single-celled status.
Regardless of the exact nature of the adaptive challenge that resulted in so many cells displaying the 2:3 ratio, the results of Xu et al. are a great example of a new cellular adaptation that can be studied at the molecular level. These findings also emphasize that even though the X chromosome in human cells used to be an autosome less than 250 million years ago (Graves, 2016), its status in cellular adaptation is distinct from autosomes, and of unique importance to the viability of cells.
References
-
Sex determination: why so many ways of doing it?PLoS Biology 12:e1001899.https://doi.org/10.1371/journal.pbio.1001899
-
Y-chromosome evolution: emerging insights into processes of Y-chromosome degenerationNature Reviews Genetics 14:113–124.https://doi.org/10.1038/nrg3366
-
The convergent cancer evolution toward a single cellular destinationMolecular Biology and Evolution 33:4–12.https://doi.org/10.1093/molbev/msv212
-
Natural selection in cancer biology: from molecular snowflakes to trait hallmarksCold Spring Harbor Perspectives in Medicine 7:a029652.https://doi.org/10.1101/cshperspect.a029652
-
Evolution of vertebrate sex chromosomes and dosage compensationNature Reviews Genetics 17:33–46.https://doi.org/10.1038/nrg.2015.2
-
Cancer as an evolutionary and ecological processNature Reviews Cancer 6:924–935.https://doi.org/10.1038/nrc2013
Article and author information
Author details
Publication history
Copyright
© 2017, Molaro et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,415
- views
-
- 317
- downloads
-
- 5
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Sex Chromosome Evolution: Culture shock
eLife 6:e33312.
https://doi.org/10.7554/eLife.33312
Further reading
-
- Evolutionary Biology
With the availability of high-quality full genome polymorphism (SNPs) data, it becomes feasible to study the past demographic and selective history of populations in exquisite detail. However, such inferences still suffer from a lack of statistical resolution for recent, for example bottlenecks, events, and/or for populations with small nucleotide diversity. Additional heritable (epi)genetic markers, such as indels, transposable elements, microsatellites, or cytosine methylation, may provide further, yet untapped, information on the recent past population history. We extend the Sequential Markovian Coalescent (SMC) framework to jointly use SNPs and other hyper-mutable markers. We are able to (1) improve the accuracy of demographic inference in recent times, (2) uncover past demographic events hidden to SNP-based inference methods, and (3) infer the hyper-mutable marker mutation rates under a finite site model. As a proof of principle, we focus on demographic inference in Arabidopsis thaliana using DNA methylation diversity data from 10 European natural accessions. We demonstrate that segregating single methylated polymorphisms (SMPs) satisfy the modeling assumptions of the SMC framework, while differentially methylated regions (DMRs) are not suitable as their length exceeds that of the genomic distance between two recombination events. Combining SNPs and SMPs while accounting for site- and region-level epimutation processes, we provide new estimates of the glacial age bottleneck and post-glacial population expansion of the European A. thaliana population. Our SMC framework readily accounts for a wide range of heritable genomic markers, thus paving the way for next-generation inference of evolutionary history by combining information from several genetic and epigenetic markers.
-
- Computational and Systems Biology
- Evolutionary Biology
There is growing interest in designing multidrug therapies that leverage tradeoffs to combat resistance. Tradeoffs are common in evolution and occur when, for example, resistance to one drug results in sensitivity to another. Major questions remain about the extent to which tradeoffs are reliable, specifically, whether the mutants that provide resistance to a given drug all suffer similar tradeoffs. This question is difficult because the drug-resistant mutants observed in the clinic, and even those evolved in controlled laboratory settings, are often biased towards those that provide large fitness benefits. Thus, the mutations (and mechanisms) that provide drug resistance may be more diverse than current data suggests. Here, we perform evolution experiments utilizing lineage-tracking to capture a fuller spectrum of mutations that give yeast cells a fitness advantage in fluconazole, a common antifungal drug. We then quantify fitness tradeoffs for each of 774 evolved mutants across 12 environments, finding these mutants group into classes with characteristically different tradeoffs. Their unique tradeoffs may imply that each group of mutants affects fitness through different underlying mechanisms. Some of the groupings we find are surprising. For example, we find some mutants that resist single drugs do not resist their combination, while others do. And some mutants to the same gene have different tradeoffs than others. These findings, on one hand, demonstrate the difficulty in relying on consistent or intuitive tradeoffs when designing multidrug treatments. On the other hand, by demonstrating that hundreds of adaptive mutations can be reduced to a few groups with characteristic tradeoffs, our findings may yet empower multidrug strategies that leverage tradeoffs to combat resistance. More generally speaking, by grouping mutants that likely affect fitness through similar underlying mechanisms, our work guides efforts to map the phenotypic effects of mutation.
